Collectively, the results of the in vivo experiments suggest that endothelial GSDMD-mediated systemic vascular injury and lethality are dependent on hepatocytic GSDMD-mediated HMGB1 release in endotoxemia. The gene discussed is GSDMD; the disease is serum lipopolysaccharide activity.